Wu, Mingxi – Trademark Portfolio

Entity Type: 01

Wu, Mingxi holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 3 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SZI, FEELOOK, HISTONE, and COLOROOM. The owner is based in Gaozhou, Guangdong.

No.104 Cengshan Village

Dong'an Town

Gaozhou, Guangdong 525200 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HISTONE
HISTONE
Registered 2021
SZI
SZI
Registered 2020
FEELOOK
FEELOOK
Registered 2020
COLOROOM
COLOROOM
Registered 2020

Trademark Classifications

Wu, Mingxi's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (3 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Wu, Mingxi have?

Wu, Mingxi has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Wu, Mingxi file in?

Wu, Mingxi files trademarks across 2 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 14 (Jewelry). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are Wu, Mingxi's most well-known trademarks?

Wu, Mingxi's registered trademark portfolio includes well-known marks such as SZI, FEELOOK, HISTONE, and COLOROOM. These are among 4 currently registered trademarks in the portfolio.

What is Wu, Mingxi's trademark registration success rate?

Wu, Mingxi has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.